Prospectus For Establishment of a DSCSA Governance Body

The latest AARP report concludes that plan members who hit this amount are expected to see savings, even when premiums are considered.

Nicholas Saraceno offers an overview of the legislation and how it impacts the pharma supply chain.

The program intends to address supply chain challenges surrounding product safety, traceability, and counterfeiting.

Dave DeJean provides his expert insight on lessons he’s learned from his plethora of time in the industry, along with an outlook on where the pharma supply chain stands in adhering to the Drug Supply Chain Security Act (DSCSA).

The Drug Supply Chain Security Act was a major coverage area for Pharma Commerce in 2024.

A session investigates the drivers of these shortages and ways to mitigate them.